Jack W. Lasersohn, Director at OncoMed Pharmaceuticals Inc (OMED), bought 11,210 shares at $14.94 ($180K) on 2015-09-30, disclosed to the SEC on 2015-10-01.
Open-market purchase of $180k OMED by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.94 | 2,090 | $31K | 17.4% |
| 2 | $16.26 | 9,120 | $148K | 82.6% |
| Total | $16.01 avg | 11,210 | $180K | 100% |
| Filing → |
| OMED | BUY | 2017-05-25 | $71K | — | Filing → |
| OMED | BUY | 2017-05-18 | $164K | — | Filing → |
| OMED | BUY | 2015-09-30 | $192K | — | Filing → |